MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/archsurg.141.9.867

Медицинская библиотека · Archives of surgery (Chicago, Ill. : 1960) · 2006

Management and outcomes of isolated axillary node recurrence in breast cancer.

Konkin David E, Tyldesley Scott, Kennecke Hagen, Speers Caroline H, Olivotto Ivo A, Davis Noelle

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

HYPOTHESIS: Management strategies affect the outcome of axillary recurrence in breast cancer.

DESIGN

Population-based analysis.

SETTING

Cancer agency breast cancer database.

PATIENTS: Two hundred twenty women diagnosed with stage 0 through III breast cancer between 1989 and 2003 who subsequently developed an isolated axillary relapse.

MAIN OUTCOME MEASURES: Overall survival rate and disease-free survival rate according to treatment strategy of the axillary recurrence.

RESULTS

Among 19 789 women diagnosed with stage 0 through III breast cancer during the study era, 220 had an isolated axillary recurrence (Kaplan-Meier 5-year isolated axillary relapse rate, 1.0%). The median interval between primary breast cancer diagnosis and axillary recurrence was 2.2 years (range,1.8 months to 11.9 years). Median follow-up time after axillary recurrence was 5.4 years. Treatment for the axillary recurrence included lymph node biopsy (47.3%), complete axillary dissection (25.9%), axillary radiation (65.0%), chemotherapy (24.1%), and hormonal therapy (68.2%). The 5-year Kaplan-Meier overall survival rate estimate after axillary recurrence was 49.3% (95% confidence interval, 42.0-56.3). Median survival time from the isolated axillary recurrence was 4.9 years (range, 2.0 months to 15.1 years). Overall (P < .001) and disease-free (P = .006) survival times were highest in those treated with a combination of surgery and radiation. Other factors associated with improved overall survival rate were an interval from diagnosis to relapse greater than 2.5 years (P = .003), no initial axillary radiation (P < .001), asymptomatic presentation of the recurrence (P = .05), and subsequent systemic treatment (P = .02).

CONCLUSIONS

The 5-year isolated axillary recurrence rate of women treated for breast cancer was 1.0%. Multimodality management at the time of recurrence, including axillary surgery, radiation, and systemic therapy, significantly improved overall and disease-free survival.

Для цитирования: Konkin David E, Tyldesley Scott, Kennecke Hagen, Speers Caroline H, Olivotto Ivo A, Davis Noelle. Management and outcomes of isolated axillary node recurrence in breast cancer.. Archives of surgery (Chicago, Ill. : 1960). 2006. DOI: 10.1001/archsurg.141.9.867.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.